首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1358093

勃起功能障礙藥物市場：依藥物、給藥途徑、配銷通路和地區

Erectile Dysfunction Treatment Market, By Drugs (Sildenafil, Vardenafil, Tadalafil, Avanafil, Udenafil, Others), By Route of Administration, By Distribution Channel, By Geography

出版日期: 2023年09月05日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2023 年全球勃起功能障礙藥物市場價值 45.4 億美元，預計在預測期內（2023-2030 年）年複合成長率為 7.6%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	45.4億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	7.60%	2030年市場規模預測	75.7億美元

勃起功能障礙藥物的全球市場佔有率（%），依產品類型，2023年

勃起功能障礙 (ED)，通常也稱為陽痿，是一種以持續或反覆無法實現和維持足以進行令人滿意的性活動的勃起為特徵的疾病。犀利士（威而鋼）、他達拉非（犀利士）、伐地那非（艾力達、Staxyn）、阿伐那非（Stendra）、烏地那非（Zydena）和其他藥物透過放鬆陰莖肌肉、增加血流量和促進勃起發揮作用。增加一氧化氮（體內的天然化學物質）的作用。

市場動態

市場上的主要企業正在專注於無機成長策略，例如勃起功能障礙（ED）的收購和交易，預計將在預測期內推動全球勃起功能障礙藥物市場的成長。例如，2022年5月，私人專業製藥公司Aspargo Laboratories, Inc.宣布從總公司西班牙巴塞隆納的專業製藥公司Laboratorios Rubio SA手中收購了處方藥品牌BANDOL（西地那非口服混懸液）。它已經收購。 BANDOL 是一種治療勃起功能障礙（ED）的藥物。此外，2023年3月，迪科特開始研發促效劑，目標是成為治療勃起功能障礙的第一線藥物，已與迪科特博士簽訂了顧問合約。 Padma-Nathan 博士參與了目前在新興市場銷售的勃起功能障礙藥物的開發，包括在威而鋼和犀利士的開發過程中擔任首席研究員。他關於威而鋼的文章發表在《新英格蘭醫學雜誌》上，是泌尿系統領域被引用次數最多的文章。

本研究的主要特點

該報告對全球勃起功能障礙治療藥物市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和復合年度（年複合成長率）。它還闡明了各個部門市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
根據公司亮點、產品系列、主要亮點、財務實績和策略等參數對全球勃起功能障礙治療藥物市場的主要企業進行了分析。
本研究涵蓋的主要企業包括 Mangoceuticals, Inc、Futura Medical、CURE Pharmaceutical Holding Corp、Glenmark Pharmaceuticals Ltd、Mylan Pharmaceuticals Inc、Boston Scientific、Cipla Ltd、Pfizer Inc、Coloplast CORP、Eli Lily &Co、Gust Inc、Altera、Promedon、 Dr. Reddys Laboratories Ltd、Bayer Pharma AG 和Reflexonic LLC。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
全球勃起功能障礙治療藥物市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球勃起功能障礙治療藥物市場的各種策略矩陣來促進他們的決策。

公司簡介
- Mangoceuticals, Inc.
- Futura Medical
- CURE Pharmaceutical Holding Corp
- Glenmark Pharmaceuticals Ltd
- Mylan Pharmaceuticals Inc
- Boston Scientific
- Cipla Ltd
- Pfizer Inc
- Coloplast CORP
- Eli Lily &Co
- Gust Inc
- Altera
- Promedon
- Dr. Reddys Laboratories Ltd
- Bayer Pharma AG
- Reflexonic LLC

第10章章

參考
調查方法

簡介目錄

Product Code: CMI200

The global erectile dysfunction treatment market is estimated to be valued at US$ 4.54 Bn in 2023 and is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 4.54 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.60%	2030 Value Projection:	US$ 7.57 Bn

Global Erectile Dysfunction Treatment Market Share (%), By Product Type, 2023

Erectile Dysfunction Treatment Market - IMG1

Erectile Dysfunction (ED), also commonly referred to as impotence, is a medical condition characterized by the consistent or recurrent inability to achieve and maintain an erection sufficient for satisfactory sexual activity. Sildenafil (Viagra), Tadalafil (Cialis), Vardenafil (Levitra, Staxyn), Avanafil (Stendra), Udenafil (Zydena), and other medications work by enhancing the effects of nitric oxide, a natural chemical in the body that relaxes the muscles in the penis, allowing for increased blood flow and thus facilitating an erection.

Market Dynamics

The key players in operating in the market are focusing on inorganic growth strategies such as acquisitions and agreements for Erectile Dysfunction (ED), which is expected to propel the global erectile dysfunction treatment market growth over the forecast period. For instance, in May 2022, Aspargo Laboratories, Inc., a privately-held specialty pharmaceutical company, announced the acquisition of the prescription brand, BANDOL (sildenafil oral suspension) from Laboratorios Rubio S.A., a specialty pharmaceutical company headquartered in Barcelona, Spain. BANDOL is indicated for the treatment of Erectile Dysfunction (ED). Moreover, in March 2023, Dicot is a pharmaceutical company started developing a novel potency drug aimed to become the first choice for treatment of erectile dysfunction, and entered into a consultancy agreement with Dr.Harin Padma-Nathan, a world leading medical expert in male sexual dysfunctions. Dr. Padma-Nathan was involved in the development of the drugs for erectile dysfunction currently on the market, e.g., as Lead Principal Investigator during the development of Viagra and Cialis. His Viagra paper in The New England Journal of Medicine is the most cited paper in the field of urology.

Key features of the study:

This report provides an in-depth analysis of the global erectile dysfunction treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global erectile dysfunction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Mangoceuticals, Inc, Futura Medical, CURE Pharmaceutical Holding Corp, Glenmark Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc., Boston Scientific, Cipla Ltd , Pfizer Inc., Coloplast CORP, Eli Lily & Co, Gust Inc, Altera, Promedon, Dr. Reddys Laboratories Ltd, Bayer Pharma AG, and Reflexonic LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global erectile dysfunction treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global erectile dysfunction treatment market

Erectile Dysfunction Treatment Market Detailed Segmentation:

By Drugs:
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
By Route of Administration:
- Oral drugs
- Injections
- Topical application
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Mangoceuticals, Inc.
- Futura Medical
- CURE Pharmaceutical Holding Corp
- Glenmark Pharmaceuticals Ltd
- Mylan Pharmaceuticals Inc.,
- Boston Scientific
- Cipla Ltd
- Pfizer Inc.,
- Coloplast CORP
- Eli Lily & Co
- Gust Inc
- Altera
- Promedon
- Dr. Reddys Laboratories Ltd
- Bayer Pharma AG
- Reflexonic LLC

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drugs
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Erectile Dysfunction Treatment Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Erectile Dysfunction Treatment Market, By Drugs, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Sildenafil (Viagra)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Vardenafil (Levitra Staxyn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Tadalafil (Cialis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Avanafil (Stendra)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Udenafil (Zydena)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Erectile Dysfunction Treatment Market, By Route of Administration, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oral Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Topical Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Erectile Dysfunction Treatment Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Erectile Dysfunction Treatment Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Mangoceuticals, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Futura Medical
- CURE Pharmaceutical Holding Corp
- Glenmark Pharmaceuticals Ltd
- Mylan Pharmaceuticals Inc
- Boston Scientific
- Cipla Ltd
- Pfizer Inc
- Coloplast CORP
- Eli Lily & Co
- Gust Inc
- Altera
- Promedon
- Dr. Reddys Laboratories Ltd
- Bayer Pharma AG
- Reflexonic LLC